Resistant hypertension and the neglected antihypertensive: Sodium restriction

Nephrology Dialysis Transplantation

Volumn 27, Issue 11, 2012, Pages 4041-4045

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

dietary intake; hypertension; resistant hypertension; sodium

Indexed keywords

ANTIHYPERTENSIVE AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; SPIRONOLACTONE;

ARTICLE; CHRONIC KIDNEY DISEASE; ESSENTIAL HYPERTENSION; HEMODIALYSIS; HUMAN; HYPERTENSION; INCIDENCE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RESISTANT HYPERTENSION; RISK FACTOR; SODIUM INTAKE; SODIUM RESTRICTION; THERAPY EFFECT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG RESISTANCE; HUMANS; HYPERTENSION; RISK FACTORS; SODIUM; SODIUM, DIETARY;

EID: 84869440990     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs384     Document Type: Article

References (29)

1. Calhoun DA, Jones D, Textor S et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
2. Persell SD. Prevalence of resistant hypertension in the United States, 2003-08. Hypertension 2011; 57:1076-1080.
3. Egan BM, Zhao Y, Axon RN et al. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 2011; 124:1046-1058.
4. Pimenta E, Calhoun DA. Resistant hypertension: incidence, prevalence, and prognosis. Circulation 2012; 125:1594-1596.
5. Daugherty SL, Powers JD, Magid DJ et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012; 125:1635-1642.
6. Pickering TG, Miller NH, Ogedegbe G et al. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 2008; 52:10-29.
7. de la Sierra A, Segura J, Banegas JR et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57:898-902.
8. Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008; 168:2340-2346.
9. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16:761-770. (Pubitemid 36007929)
10. He FJ, MacGregor GA. Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension 2006; 48:861-869. (Pubitemid 44610998)
11. Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3-10. (Pubitemid 32064838)
12. Henney JE, Taylor CL, Boon CS. Strategies to Reduce Sodium Intake in the United States. Washington, DC: The National Academies Press, 2010, pp. 1-506
13. Bibbins-Domingo K, Chertow GM, Coxson PG et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362:590-599.
14. Pimenta E, Gaddam KK, Oparil S et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54:475-481.
15. Fotherby MD, Potter JF. Effects of moderate sodium restriction on clinic and twenty-four-hour ambulatory blood pressure in elderly hypertensive subjects. J Hypertens 1993; 11:657-663. (Pubitemid 23225209)
16. Gavras H, Waeber B, Kershaw GR et al. Role of reactive hyperreni-nemia in blood pressure changes induced by sodium depletion in patients with refractory hypertension. Hypertension 1981; 3:441-447. (Pubitemid 11002041)
17. Vogt L, Waanders F, Boomsma F et al. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 2008; 19:999-1007.
18. Swift PA, Markandu ND, Sagnella GA et al. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension 2005; 46:308-312. (Pubitemid 41099162)
19. Agarwal R. Epidemiology of interdialytic ambulatory hypertension and the role of volume excess. Am J Nephrol 2011; 34:381-390.
20. Agarwal R, Weir MR. Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 2010; 5:1255-1260.
21. Agarwal R, Alborzi P, Satyan S et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53:500-507.
22. Mc Causland FR, Waikar SS, Brunelli SM. Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int 2012; 82:204-211.
23. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 2004; 43:142-146. (Pubitemid 38174163)
24. Ying WZ, Sanders PW. Dietary salt increases endothelial nitric oxide synthase and TGF-beta1 in rat aortic endothelium. Am J Physiol 1999; 277: H1293-H1298 (Pubitemid 29522657)
25. Sanders PW. Assessment and treatment of hypertension in dialysis: the case for salt restriction. Semin Dial 2007; 20:408-411.
26. Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 2007; 356:1966-1978.
27. Bommel EV, Cleophas T. Potassium treatment for hypertension in patients with high salt intake: a meta-analysis. Int J Clin Pharmacol Ther 2012; 50:478-482.
28. Stolarz-Skrzypek K, Kuznetsova T, Thijs L et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011; 305:1777-1785.
29. Bussemaker E, Hillebrand U, Hausberg M et al. Pathogenesis of hypertension: interactions among sodium, potassium, and aldosterone. Am J Kidney Dis 2010; 55:1111-1120.